China Life Insurance, the largest life insurer in China, reported record-breaking financial results for the first half of the year. According to the company's interim report, revenue reached 434.3 billion yuan (US$64.6 billion), marking an 81.5% increase compared to the same period last year. Net profit saw an even steeper rise, climbing over 228% to reach 134.5 billion yuan.

Following these results, the company announced a strategic shift toward increasing its long-term investments in high-growth technology sectors. Specifically, China Life intends to allocate more capital toward artificial intelligence, semiconductor manufacturing, and biotechnology. By positioning itself as a long-term partner for innovative enterprises, the insurer aims to diversify its portfolio beyond traditional insurance assets. These results are listed on both the Shanghai and Hong Kong stock exchanges, reflecting a period of significant financial expansion for the state-backed firm.